Latest Channelopathy Stories
Cystic fibrosis medicines that help to break down mucus in the lungs may carry an unexpected long-term benefit, a study suggests.
LINCOLN, R.I., May 28 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc. today announced that the Company's product candidate, NT-501, demonstrated a strong biologic effect in two Phase 2 clinical trials for retinitis pigmentosa (RP).
WASHINGTON, May 21 /PRNewswire-USNewswire/ -- Before your kids are out the schoolroom door and off to the pool or baseball field this summer, take a few preventive steps to help protect their hearts. Prevention may be as simple as making sure children eat nutritious meals, exercise, stay away from cigarettes and have check-ups. Be aware that for some children who have an inherited heart disorder known as Long QT Syndrome, research shows that typical summer activities can trigger sudden...
U.S. pharmaceutical researchers say a new sodium channel blocker is showing promise as a potential treatment for cystic fibrosis. Scientists who developed the drug at Parion Sciences Inc.
Cystic fibrosis patients may benefit from a new therapy that increases airway hydration, preventing the buildup of mucous, which is a key factor in the disease, according to researchers at Parion Sciences in Durham, N.C.
The mystery of genetic disease is only partially solved with the identification of a mutated gene. Often, the pattern of disease â€“ the features or disorders associated with it â€“ vary in type and severity among those who are affected. Scientists, physicians and patients all ask why.
WASHINGTON, April 29 /PRNewswire/ -- Vision loss is a high priority area for VA Research.
Omega three fatty acids protect brain cells by preventing the misfolding of a protein from a gene mutation in Parkinson's disease, U.S. researchers said. Dr. Nicolas Bazan of Louisiana State University and colleagues developed a cell model with a mutation of the Ataxin-1 gene.
OMAHA, Neb., April 2 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO).
A U.S.-German study has linked 10 genes with sudden cardiac death, a condition that accounts for 450,000 U.S.
Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...
- In medieval musical notation, a sign or neume denoting a shake or trill.